Sign in
4

Changes in Ownership

PTC THERAPEUTICS, INC. Filed Acc 0001415889-24-002173

EXEC. VP AND CLO sold 794 shares at $27.25 ($21,637)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Boulding Mark Elliott EXEC. VP AND CLO 2024-01-30 Sale 10b5-1 −794 $27.25 $21,637 71,189 D
Open-market sales · 794 sh · avg $27.25 · $21,637
Loading xslF345X05/form4-02012024_090230.xml…